Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Atopy of the skin is manifested as atopic dermatitis (atopic eczema).
Histologically, the atopy of the skin is characterized by epidermal and dermal infiltration predominantly by lymphocytic cells as well as eosinophils and mast cells. In some patients, the granular cell layer is diminished because of the absence of filaggrin protein.
The skin surface of patients affected by skin atopy is commonly characterized by lack of proper hydration (xerosis), and some patients have a genetic mutation of a key skin barrier component, filaggrin. We frequently observe pathogenic Staphylococcus colonization, with a relative decrease in commensal bacteria and overall microbial diversity, a phenomenon known as dysbiosis.
Physiologically, patients affected by skin atopy bear heavy burdens of itch and pain, which in turn affects patients’ sleep, circadian rhythm, and overall health. Severe disease associates with cardiovascular and cerebrovascular comorbidities.
On the immunologic aspect, patients affected by skin atopy typically have deviations of both innate and adaptive systems. The documented findings include deficiency in antimicrobial peptides and helper T-cell imbalance that favors Th2 with upregulation on the expressions of interleukin-4 (IL4), IL5, IL10, IL13, IL31, and serum immunoglobulin E (IgE).
When atopy occurs in the skin, the medical term is atopic dermatitis or atopic eczema . In this chapter, a bird’s-eye view on major aspects of atopic dermatitis will be discussed, including the histology of inflammatory skin lesion, the skin surface abnormalities, the physiologic abnormalities of atopic dermatitis, and the altered immune milieu. The chapters that follow will expand the overview of atopic dermatitis with detailed delineation. This chapter, in fact, is the miniature representation of this entire book on clinical and basic sciences of atopic dermatitis.
Historically, one of the earliest attempts by the medical community to understand the pathomechanism of disease is through a microscopic examination of disease tissue (histopathology), as it is an identification of what the disease is and what damages the disease causes at the tissue level. The basic process involves getting the disease tissue, preserving the tissue with formaldehyde (formalin), dehydrating the tissue in graded alcohol, embedding and hardening the tissue in paraffin, sectioning and placing thin sections of tissue on glass slides, rehydrating the tissue, and staining the tissue sections with routine combination stain of hematoxylin (for cell nucleus) and eosin (for cellular cytoplasm). After mounting the stained tissues with a coverslip, the tissues on slides can then be examined microscopically. Although not particularly high-tech compared to newer diagnostic methods, histopathology provides very important information regarding a particular disease, including tissues and level affected, structures and/or cells damaged, invading pathogens detected, inflammatory cells involved, cancerous cell type identified, and boundary of the cancerous tissue delineated. When needed, special stains other than hematoxylin/eosin are used to detect other components with better visualization. Giemsa stain is used to identify mast cells, periodic acid–Schiff (PAS) stain detects fungal elements, Gram stain reveals bacteria, Warthin-Starry stain labels spirochetes bacteria, and acid-fast stain identifies mycobacteria ( ). Besides these special staining techniques that utilize chemical stains, immunohistochemistry staining methods use antibody to identify certain cellular components for visualization after the sectioned tissues undergo certain antigen retrieval steps. These retrieval steps are necessary since formalin fixation disguises the antigenic epitope, and the unmasking steps are required to make these antigenic epitopes available for the antibody binding ( ). Tissues obtained for regular histopathology can also be specially preserved and processed for electron microscopic examination if indications for the more detailed examination arise ( ). We can apply molecular diagnostic methods to the tissue sections processed through the routine formalin-fixed paraffinized tissues as well ( ).
In the nonvesicular lesional skin of atopic dermatitis, one can commonly visualize a picture of inflammation with the following findings under the microscope ( Fig. 3.1 ). In the acute inflammatory lesion, the epidermis shows psoriasiform hyperplasia and intercellular edema. Epidermal and dermal white blood cell infiltrations are composed primarily of lymphocytes with occasional monocytes/macrophages, neutrophils, eosinophils, and basophils. Mast cells and Langerhans cells are present. We can also observe some vascular changes, including endothelial cell hypertrophy, rare endothelial mitosis, and large activated nuclei, suggesting a process of angiogenesis. In chronically inflamed lesion, the epidermis is visibly different from the acute lesion, with the presence of hyperkeratosis and dyskeratosis besides psoriasiform hyperplasia. Varying degrees of intercellular edema and a few lymphocytes are present. In the dermis there are a moderate number of lymphocytes and monocytes/macrophages. The number of mast cells significantly increases ( ). The thickness of the granular layer of the epidermis in atopic dermatitis lesion can be similar to that of normal individuals, unless atopic dermatitis occurs in a person who has filaggrin gene mutation with a corresponding reduction of granular cell layer ( ). More details of filaggrin mutation in atopic dermatitis are discussed in Chapter 5, Chapter 11 .
The initial discovery of loss-of-function genetic mutation of filaggrin in nearly 50% of white patients affected by atopic dermatitis opens a new scientific window into the disease mechanism of atopic dermatitis and atopy in general ( ). However, researchers subsequently determined that the filaggrin mutation occurred in much lower frequency in nonwhite atopic dermatitis patients ( ). Whether atopic dermatitis patients have other skin barrier protein defects aside from filaggrin is not known at the present time. Although some patients do not have a genetic mutation of skin barrier proteins, their barrier proteins can be deficient secondary to the Th2 cytokine upregulation. Experimentally, human epidermal keratinocytes, under the influence of IL4, or a combination of IL4/IL13, reduce their ability to synthesize various skin barrier proteins such as filaggrin, involucrin, and loricrin ( ). Thus, in clinically observed inflammatory skin lesions, these skin barrier proteins may in fact be reduced secondary to inflammation without the corresponding gene mutation.
Intimately related to skin barrier function, skin hydration is reduced in patients affected by atopic dermatitis. Xerosis (dry skin) is a common finding in skin of atopic dermatitis patients and is a clinical diagnostic criterion for atopic dermatitis ( ). This improper hydration condition in atopic skin, predisposed to penetration of irritants and allergens, is documented by an increase of transepidermal water loss ( ). More discussions on skin barrier defect in atopic dermatitis are available in Chapter 5, Chapter 11, Chapter 15, Chapter 22 .
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here